AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 14, 2022

The medical devices industry in the country has sought the Centre to define online and offline mode of sale, provide more clarity on the regulations that are binding the online sales and suggested inclusion of online medical devices players under the Uniform Code for Medical Devices Marketing Practices (UCMDMP).

Sales 182

Sales Regulation Marketing Drugs 182

XTalks

MARCH 14, 2025

mg), underperformed in its latest clinical trial, leading to a dip in the companys share price. In response to the trial outcomes, Novos shares declined by approximately 8% this week. Novo shared the latest data from the Phase III REDEFINE 2 trial evaluating the drug in overweight or obese patients with type 2 diabetes.

Trials 89

Trials Drugs Clinical Trials Clinical Trials 89

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2024

The Drugs Technical Advisory Board (DTAB) of the Union health ministry has once again recommended prohibiting the manufacture, sale and distribution of pain relief drug combination S(+) etodolac+paracetamol, after considering a sub-committee report.

Manufacturing 246

Manufacturing Sales Drugs Clinical Trials 246

World of DTC Marketing

OCTOBER 21, 2021

SUMMARY: Medicare spent nearly $600 million over a three-year period to pay for four cancer drugs with no clinical benefit an analysis published Monday by JAMA Internal Medicine found. billion, with more than half of that devoted to products that did not provide a “documented overall survival benefit” in clinical trials.

Clinical Trials 234

Clinical Trials Clinical Trials FDA Approval Trials 234

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 12, 2025

But it can be hard to work out the difference between all the types on sale. (Laura Leyshon/Getty Images) If you head to the shops to buy bread, you’ll face a variety of different options. For instance, you might have a vague idea that wholemeal or wholegrain bread is healthy. But what’s the difference? Here’s […]

Sales 210

Sales Clinical Trials Clinical Trials Trials 210

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 10, 2022

A new anti-hangover supplement has just gone on sale in the UK. It is marketed by Swedish firm Myrkl as “the pre-drinking pill that works” The pill is said to break down up to 70 percent of alcohol after 60 minutes. This means that if someone drinks 50 ml of 40 percent spirits, which contains […].

Containment 246

Containment Sales Marketing Clinical Trials 246

Pharmaceutical Technology

APRIL 4, 2023

billion sales for Erleada, a jump from $1.2 Amidst the drive to offer dosing flexibility for everyday use, attention has also turned to studying different dosing regimens in clinical trials. In some conditions like substance use disorders, experts say that higher doses in less quantity improves adherence in clinical trials.

Drugs 245

Drugs Clinical Trials Clinical Trials Sales 245

World of DTC Marketing

APRIL 11, 2021

Both Pfizer and Moderna stand to make billions, and even though J&J said they would not make money on the first batch, they are already positioning yearly Covid Vaccine shots that could net them billions in sales. Plus, clinical trial settings aren’t always the same as real-world settings. Do Lockdowns Work?

Vaccine 303

Vaccine Vaccination Clinical Trials Clinical Trials 303

Pharmaceutical Technology

NOVEMBER 22, 2022

The latest development is based on the expected efficacy of the drug and the acceptability of its safety profile reported from a Phase II/III clinical trial. An oral antiviral, Xocova is given once a day for five days to suppress SARS-CoV-2 replication by selectively hindering the viral 3CL protease.

Drugs 246

Drugs Clinical Trials Clinical Trials Sales 246

Pharmaceutical Technology

NOVEMBER 8, 2022

Additionally, Neurophth will oversee the clinical trials and marketing of gene therapy products developed leveraging the new AAV capsids of Cyagen. Under the collaboration, Cyagen is entitled to get research phase and clinical phase milestone payments and sales-based royalty payments totalling over $140m.

Gene Therapy 305

Gene Therapy Gene Development Genetics 305

XTalks

NOVEMBER 21, 2024

While GlobalData predicts that Mounjaro and Zepbound will contribute to GLP-1 drugs becoming the best-selling drug class this year, sales of the drugs have been slightly lower than anticipated. In the third quarter of 2024, Mounjaro’s type 2 diabetes sales reached $3.11 Similarly, Zepbound’s sales in obesity totaled $1.26

Sales 105

Sales Insulin Drugs Trials 105

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 23, 2023

With the chemists and druggists across the country opposing the sale of drugs through online, the Central government is taking a stand that the sale of medicines should be strictly under the provisions of the existing regulations and the State Licensing Authorities (SLAs) are legally empowered to act against violation of the legal provisions.

Pharmacy 188

Pharmacy Sales Licensing Licensing 188

Pharmaceutical Technology

MAY 19, 2023

AbbVie anticipates Rinvoq sales to exceed $7.5bn in 2025 and for the peak revenues from both drugs to exceed Humira’s peak sales by 2027. The FDA has recommended that patients start with 45mg Rinvoq once daily for 12 weeks, with a maintenance dosage of 15mg following the 12-week period.

FDA Approval 264

FDA Approval Dermatology Sales Clinical Trials 264

XTalks

JANUARY 6, 2025

In clinical trials, Alyftrek demonstrated non-inferiority to Trikafta, showing similar improvements in lung function and a reduction in sweat chloride levels. Related: Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data Alyftrek will soon be available to US patients, offering a critical alternative to current therapies.

Gene Therapy 105

Gene Therapy Protein Genetic Disease Gene 105

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 17, 2024

Roche had sought injunctive reliefs against the sale and distribution of Sigrima and Womab, which purportedly infringes […] As per the Delhi HC order, Zydus and Dr Reddy’s launched ‘Sigrima/Womab,’ a biosimilar of Roche’s ‘Perjeta’ (pertuzumab), in a clear contempt of court.

Sales 189

Sales Clinical Trials Clinical Trials Clinical Research 189

pharmaphorum

DECEMBER 23, 2022

A unified view of the HCP will emerge from clinical to commercial. Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer. Incentive compensation models will reward the right omnichannel behaviours. “In

Sales 105

Sales Marketing Life Science Compliance 105

Pharmaceutical Technology

NOVEMBER 21, 2022

At present, bomedemstat is being analysed in various Phase II clinical trials to treat myelofibrosis, essential thrombocythemia and polycythemia vera, apart from various other indications. The lead candidate of the company bomedemstat (IMG-7289) is an investigational, orally available inhibitor of lysine-specific demethylase 1 (LSD1).

Clinical Trials 246

Clinical Trials Clinical Trials Clinical Development Sales 246

Pharmaceutical Technology

DECEMBER 19, 2022

Innate is also eligible to receive a total of up to $1.43bn (€1.35bn) in preclinical, clinical, regulatory and commercial milestone payments and royalty payments on net sales in the future. Under the latest licence deal, Sanofi will make an upfront payment of $26.4m (€25m) to Innate.

Development 264

Development Engineer Clinical Trials Clinical Trials 264

Pharmaceutical Technology

MAY 8, 2023

Currently, BB-1701 is being evaluated in Phase I/II trials in China and the US. Under the deal terms, Eisai will conduct a Phase II clinical trial of BB-1701 in breast cancer and make upfront and development milestone payments to BlissBio.

Development 246

Development Antibody Clinical Trials Clinical Trials 246

Pharmaceutical Technology

MAY 12, 2023

On 8 May 2023, China-based Bliss Biopharmaceutical (BlissBio) announced a clinical trial collaboration with Eisai to develop BB-1701, an antibody-drug conjugate (ADC) for multiple cancer types. The drug became a blockbuster last year, with sales reaching $1.9bn, up from $599m in 2021. targeting ADC.

Clinical Trials 162

Clinical Trials Clinical Trials Licensing Licensing 162

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 4, 2023

The Union health ministry has issued a draft notification to include antiviral drugs oseltamivir and zanamivir into the Schedule H1 of the Drug Rules, 1945, allowing the retailers to store and sell the drug against prescription by maintaining a separate record for the details of the particular sales.

Drugs 189

Drugs Sales Clinical Trials Clinical Trials 189

Pharmaceutical Technology

NOVEMBER 11, 2022

For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%. AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter.

FDA Approval 242

FDA Approval Clinical Trials Clinical Trials Sales 242

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 7, 2023

The Union health ministry has issued a notification prohibiting the manufacture, sale and distribution of pain killers, ketoprofen and aceclofenac and their formulations for animal use with immediate effect, as they are likely to involve risk to animals.

Sales 187

Sales Manufacturing Clinical Trials Clinical Trials 187

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 11, 2023

The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]

Pharma Companies 186

Pharma Companies Licensing Licensing Sales 186

World of DTC Marketing

FEBRUARY 7, 2022

” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). ” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). At 99% of pharma companies, that's a huge no-no. Click to Tweet.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Pharma Mirror

OCTOBER 22, 2021

ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled “Getting it right! Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D,

Vaccine 130

Vaccine Vaccination Clinical Trials Clinical Trials 130

XTalks

NOVEMBER 7, 2024

Emrosi’s approval was based on data from a pair of Phase III clinical trials for the treatment of rosacea. The trials met all co-primary and secondary endpoints, with participants having successfully completed the 16-week treatment with no significant safety issues.

FDA Approval 105

FDA Approval Dermatology Bacteria Clinical Trials 105

Pharmaceutical Technology

OCTOBER 5, 2022

According to GlobalData’s analyst consensus forecast, Yescarta is expected to reach peak sales of $1.8bn in 2028, and Kymriah is expected to reach sales of $686m in the same year.

In-Vitro 279

In-Vitro In-Vivo Sales Clinical Trials 279

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 16, 2023

At least seven more pharma companies and a federation of pharma manufacturers have approached the Delhi High Court against the Central Government’s order in the beginning of June prohibiting manufacturing, distribution and sale of 14 fixed dose combinations (FDCs) licensed prior to the year 1988.

Pharma Companies 188

Pharma Companies Licensing Licensing Manufacturing 188

Pharmaceutical Technology

DECEMBER 12, 2022

An investigational late-stage product candidate, CART-ddBCMA is being analysed in the Phase II iMMagine-1 clinical trial at present. The development, clinical trial and marketing expenses for the cell therapy will be shared by the companies while co-commercialising the product and equally splitting profits from the US region.

Development 264

Development Gene Therapy Clinical Trials Clinical Trials 264

Pharmaceutical Technology

MAY 1, 2023

The NDA is supported by the data package licensed to Ocumension by Nicox as well as the Phase III clinical trial in China. sales milestones along with royalties ranging between 5% and 9% of net sales of the solution by Ocumension.

Licensing 162

Licensing Licensing Sales Packaging 162

World of DTC Marketing

JANUARY 11, 2022

In response, pharma companies had to train their sales force to use digital channels and help them have valuable discussions with HCPs virtually. Given the critical connection of the sales force between the industry and HCPs, companies who do not prioritize this stand to lose out on their ability to engage physicians.

Pharma Companies 235

Pharma Companies Sales Marketing Clinical Trials 235

Pharmaceutical Technology

MAY 15, 2023

Sanofi announced data from a real-world clinical trial that demonstrated its RSV antibody nirsevimab delivered an 83% reduction in hospitalisations in infants with respiratory syncytial virus (RSV)-related lower respiratory tract disease (LRTD). Nirsevimab is being jointly developed between Sanofi and AstraZeneca.

Antibody 245

Antibody Vaccine Vaccination Trials 245

Pharmaceutical Technology

NOVEMBER 29, 2022

According to the deal, Focus-X shareholders are entitled to receive an upfront payment, potential development, and regulatory and sales-based milestones of up to $245m, in addition to royalties on any commercial sales. Additionally, Full-Life will make royalty payments to Focus-X on any commercial sales.

Sales 147

Sales Engineer DNA Development 147

World of DTC Marketing

JUNE 2, 2021

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. It can’t be promotional or sales information and should not be a long document. 100 percent of U.S.

Doctor 180

Doctor Doctors Sales Marketing 180

STAT News

DECEMBER 12, 2022

However, hopes the drug might reach a large swath of patients — and grow into a commercial blockbuster for its maker Mirati Therapeutics — have dimmed in the wake of underwhelming clinical trial results.

FDA Approval 98

FDA Approval Sales Drugs Clinical Trials 98

Pharmaceutical Technology

DECEMBER 15, 2022

In an expanded version of the sales forecast from GlobalData’s June 2022 publication, Cardiomyopathies: Global Drug Forecast and Market Analysis , the global cardiomyopathies market is expected to grow from $3.07bn last year to $9.63bn in 2031. of sales in 2021 and 2031 respectively. of global cardiomyopathies sales in 2021 and 31.2%

Marketing 130

Marketing Sales Clinical Trials Clinical Trials 130